| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Skovronsky Daniel | EVP, CS&PO & Pres. LRL | LILLY CORPORATE CENTER, INDIANAPOLIS | /s/ Jonathan Groff for Daniel Skovronsky, pursuant to authorization on file | 03 Feb 2026 | 0001741474 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Options Exercise | $0 | +12,684 | +9.2% | $0.000000 | 150,165 | 01 Feb 2026 | Direct | |
| transaction | LLY | Common Stock | Tax liability | $5,850,821 | -5,641 | -3.8% | $1037.15 | 144,524 | 01 Feb 2026 | Direct | |
| holding | LLY | Common Stock | 72,359 | 01 Feb 2026 | By Trust | F1 | |||||
| holding | LLY | Common Stock | 547 | 01 Feb 2026 | By spouse | F1 | |||||
| holding | LLY | Common Stock | 2,710 | 01 Feb 2026 | By spouse's SLAT | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Options Exercise | $0 | -12,684 | -100% | $0.000000 | 0 | 01 Feb 2026 | Common Stock | 12,684 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |